TimesSquare Capital Management, LLC 13D and 13G filings for Tarsus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-02 06:05 am Sale |
2023-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
TimesSquare Capital Management, LLC | 0 0.000% |
-1,429,310 (Position Closed) |
Filing |
| 2023-02-03 08:16 am Purchase |
2022-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
TimesSquare Capital Management, LLC | 1,429,310 5.360% |
1,429,310 (New Position) |
Filing |